Related Experiment Video
Updated: Feb 1, 2026

Protocol for Production of a Genetic Cross of the Rodent Malaria Parasites
Published on: January 3, 2011
Fighting Cancer Using an Oncofetal Glycosaminoglycan-Binding Protein from Malaria Parasites
Mette Ø Agerbæk1, Sara Bang-Christensen1, Ali Salanti1
1Centre for Medical Parasitology at Department of Immunology and Microbiology, University of Copenhagen and Department of Infectious Diseases, Copenhagen University Hospital, Copenhagen, Denmark.
Abstract:
Malaria research has led to the discovery of oncofetal chondroitin sulfate, which appears to be shared between placental trophoblasts and cancer cells and can be detected by the evolutionary refined malaria protein VAR2CSA. Interestingly, using recombinant VAR2CSA to target oncofetal chondroitin sulfate shows promise for novel cancer diagnostics and therapeutics.
Insights
Malaria research identified oncofetal chondroitin sulfate, a molecule shared by placental cells and cancer cells. The malaria protein VAR2CSA can target this molecule, offering potential for new cancer diagnostics and therapies.
Area of Science:
- Biochemistry
- Oncology
- Parasitology
Background:
- Malaria research has uncovered unique molecular interactions.
- Oncofetal chondroitin sulfate (ofCS) is expressed in placental trophoblasts.
- Cancer cells can also express ofCS, suggesting a potential shared marker.
Purpose of the Study:
- To investigate the potential of oncofetal chondroitin sulfate as a common marker for cancer.
- To explore the utility of the malaria-derived protein VAR2CSA in targeting ofCS.
Main Methods:
- Utilizing insights from malaria research.
- Employing the malaria protein VAR2CSA as a targeting agent.
- Investigating the interaction between VAR2CSA and ofCS.
Main Results:
- Oncofetal chondroitin sulfate (ofCS) was identified through malaria research.
- The malaria protein VAR2CSA effectively detects ofCS.
- ofCS is present on both placental trophoblasts and cancer cells.
Conclusions:
- The malaria protein VAR2CSA can target oncofetal chondroitin sulfate.
- This interaction shows promise for developing novel cancer diagnostics.
- The findings suggest potential for new cancer therapeutics based on VAR2CSA-ofCS targeting.
More Related Videos
09:13Author Spotlight: Identifying Compensatory Pathways in Malaria Parasites Containing Hypomorphic Allele of Essential Protein Kinases
Published on: November 22, 2024
09:25CRISPR/Cas9 Gene Editing to Make Conditional Mutants of Human Malaria Parasite P. falciparum
Published on: September 18, 2018
Related Concept Videos
Glycosaminoglycans
GAGS are found in the extracellular matrix of vertebrates, invertebrates, and bacteria. Due to their polar nature they attract water, and serve as excellent lubricants or shock absorbers in an animal body.
Hyaluronic...
Factors Affecting Protein-Drug Binding: Protein-Related Factors
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be...
The Equilibrium Binding Constant and Binding Strength
Drug Distribution: Plasma Protein Binding
Protein-Drug Binding: Determination Methods
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...
Single-Strand DNA Binding Proteins